A detailed history of Gsa Capital Partners LLP transactions in Rx Sight, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 21,084 shares of RXST stock, worth $709,687. This represents 0.08% of its overall portfolio holdings.

Number of Shares
21,084
Previous 35,856 41.2%
Holding current value
$709,687
Previous $2.16 Million 51.69%
% of portfolio
0.08%
Previous 0.15%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$40.78 - $57.04 $602,402 - $842,594
-14,772 Reduced 41.2%
21,084 $1.04 Million
Q2 2024

Aug 15, 2024

SELL
$50.42 - $64.29 $77,293 - $98,556
-1,533 Reduced 4.1%
35,856 $2.16 Million
Q1 2024

May 03, 2024

BUY
$35.51 - $57.92 $1.33 Million - $2.17 Million
37,389 New
37,389 $1.93 Million
Q3 2023

Nov 15, 2023

SELL
$27.05 - $33.37 $288,082 - $355,390
-10,650 Reduced 32.1%
22,532 $628,000
Q2 2023

Aug 14, 2023

BUY
$16.37 - $28.9 $543,189 - $958,959
33,182 New
33,182 $955,000

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $930M
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.